Ferry D R, Rombush M, Goll A, Glossmann H
FEBS Lett. 1984 Apr 9;169(1):112-8. doi: 10.1016/0014-5793(84)80299-9.
A 1,4-dihydroypyridine arylazide photoaffinity ligand, [3H]azidopine (50.6 Ci/mmol), has been synthesized. [3H]Azidopine binds reversibly with a Kd of 350 pM to guinea-pig skeletal muscle membranes in the absence of ultraviolet light. The reversible [3H]azidopine binding is inhibited steroselectively by 1,4-dihydropyridines, phenylalkylamine Ca2+ channel blockers and La3+. Covalent incorporation into membrane proteins after photolysis was investigated by sodium dodecyl sulfate polyacrylamide slab gel electrophoresis. [3H]Azidopine is photoincorporated specifically into a protein of Mr approximately 145 000. The covalent labelling of the Mr approximately 145 000 band is inhibited stereoselectively by drugs and cations which block the reversible [3H]azidopine binding. It is suggested that [3H]azidopine is photoincorporated into a subunit of the putative Ca2+ channel.
已合成一种1,4 - 二羟基吡啶芳基叠氮光亲和配体,即[³H]叠氮平(50.6 Ci/mmol)。在无紫外光条件下,[³H]叠氮平以350 pM的解离常数与豚鼠骨骼肌膜可逆结合。1,4 - 二氢吡啶、苯烷基胺类钙离子通道阻滞剂和La³⁺可立体选择性抑制[³H]叠氮平的可逆结合。通过十二烷基硫酸钠聚丙烯酰胺平板凝胶电泳研究了光解后[³H]叠氮平共价掺入膜蛋白的情况。[³H]叠氮平特异性光掺入一种分子量约为145000的蛋白质中。分子量约为145000条带的共价标记被阻断[³H]叠氮平可逆结合的药物和阳离子立体选择性抑制。提示[³H]叠氮平光掺入假定的钙离子通道亚基中。